Vaccine for eliciting immune response comprising RNA encoding an immunogen and lipid formulations comprising mole percentage of lipids | Patent Number 11638693

US 11638693 B2
Application Number17808519
Publication NumberUS 20220362152 A1
Pendency10 months, 13 days
Filled DateJun 23, 2022
Priority DateJul 6, 2010
Publication DateNov 17, 2022
Expiration DateJul 5, 2030
Inventor/ApplicantsAndrew Geall
ExaminesLEONARD, ARTHUR S
Art Unit1631
Technology Center1600
Assignments
Glaxo Group Limited
Current
Glaxosmithkline Biologicals SaGlaxo Group Limited
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.